2. The Fundamentals of Cancer
• The ability of cancer
cells to sustain chronic
proliferation is
fundamental
• Allows cancer cells to
grow into tumors,
metastasize, and
invade other regions
of the body
(Hanahan and Weinberg, 2011)
5. Sustained Proliferative Signaling
• Cancer cells maintain
constant growth through
sustaining proliferative
signaling
• Deregulation of cell
signaling pathways allows
cancers cells to
upregulate growth signals
and downregulate anti-
growth signals
6. The Stages of Cell Signaling
1. Reception: Binding between a ligand molecule
and receptor; highly specific
2. Transduction: conversion of a signal to a form
that can bring about a specific response via
phosphorylation cascade, protein kinases, and
second messengers
3. Response: Regulation of gene expression or
cytoplasmic activities
8. Mechanisms of Proliferative Signaling
• Normal cells require
mitogenic growth
signals in order to
proliferate
• Cancer cells acquire
growth signal
autonomy in a
variety of ways
(Hanahan and Weinberg, 2011)
9. Production of Growth Signals
• Cancer cells produce their own growth signals
• Ability to synthesize growth factors and
signaling molecules to which they are
responsive (Fedi et al., 1997)
• Creates positive feedback loop for cell growth
• Example: Production of PDGT and TGF-alpha
by glioblastomas and sarcomas (Fedi et al.,
1997)
10. Overexpression of Receptors
• Cancer cells over-express receptor proteins, in
particular, growth factor receptors
• Causes cancer cells to become hyper-
responsive to external growth signals (Fedi et
al., 1997)
• Example: Epidermal GF receptor is up-
regulated in stomach, brain, and breast
tumors (Slamon et al.,1987)
11. Ligand-Independent Signaling
• Over-expression of growth factor receptors
induces ligand-independent signaling (DiFoire
et al., 1987)
• No need for signaling molecules to trigger cell
division and growth
• Same result achieved through structural
alterations of receptor proteins
• Example: Modified EGF receptor induces non-
stop signaling (Fedi et al., 1997)
12. Downstream Alterations
• Downstream alterations of intracellular
circuits can trigger proliferative signaling
• SOS-Ras-Raf-MAP Kinase growth pathway
• Example: In 25% of tumors, Ras proteins are
modified to induce mitogenic signals
downstream of the GF receptor (Medema and
Bos, 1993)
13.
14. Recruitment of Normal Cells
• Cancer cells recruit normal cells neighbors to
supply growth factors and signals
• Cancer cells stimulate normal cells to release
growth factors into the tumor
microenvironment (Cheng et al., 2008;
Bhowmick et al., 2004)
• Key role of fibroblasts and endothelial cells
• Paracrine signaling vs. endocrine signaling
15. The Genetic Basis of Unregulated
Growth: Mutation
• Genetic mutation leads to
cancer
• Over-expression of
oncogenes, under-expression
of tumor suppressor genes
• Mutations in oncogenes
mimic growth signaling
(Hanahan and Weinberg,
2000)
• About half of human tumors
have mutant Ras oncogenes
(Kinzler and Vogelstein,
1996)
16. New Research
• Somatic mutations activate additional downstream
pathways
• About 40% of human melanomas contain
mutations affecting B-Raf proteins in the MAP-
kinase pathway (Davies and Samuels, 2010)
• Defects in negative-feedback loops promote
proliferative signaling
• Mutations in Ras oncogenes compromise GTPase
activity, which regulates proliferative signaling
(Hanahan and Weinberg, 2011)
17. Reference
Hanahan, D., & Weinberg, R. A. (2011). Hallmarks of Cancer:
The Next Generation. Cell, 144, 646-674.
Hanahan, D., & Weinberg, R.A. (2000). The Hallmarks of
Cancer. Cell, 100, 57-70